Macmahon to acquire Aspect Engineering for $75M
Macmahon (ASX:MAH) has executed a share purchase agreement to acquire 100% of Aspect Engineering Solutions for an enterprise value of $75 million.
Macmahon (ASX:MAH) has executed a share purchase agreement to acquire 100% of Aspect Engineering Solutions for an enterprise value of $75 million.
The Australian federal government is assessing a potential ban on camera-equipped smart glasses across Commonwealth workplaces, Centrelink service centres, and CSIRO laboratories.
Ramsay Santé presented its Connecting Care 2030, targeting annual revenue growth of approximately 3.0% through FY29.
Data centre developer Firmus is targeting an initial public offering on Oct. 22 that could value the business at up to US$60 billion.
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) received authorization from Health Canada for their Omicron XFG-adapted COVID-19 vaccine.
Intuit (NASDAQ:INTU) provided fiscal 2027 guidance, expecting full-year revenue of $23.28 billion to $23.51 billion and first-quarter revenue of $4.29 billion to $4.31 billion.
Surgery Partners (NASDAQ:SGRY) updated its 2026 financial outlook following the completed sale of its Idaho Falls facilities to Intermountain Health.
Olenox Industries (NASDAQ:OLOX) reported that its CS Digital Ventures operations mined approximately 15.63 Bitcoin in August 2026 as the company continued operating its digital asset mining infrastructure.
MIRA Pharmaceuticals (NASDAQ:MIRA) submitted a Phase 2a clinical trial protocol for Ketamir-2 in chemotherapy-induced peripheral neuropathy (CIPN) following review and feedback from the U.S. Food and Drug Administration.
Applied Materials (NASDAQ:AMAT) announced plans to invest $5 billion in India over the next decade as the semiconductor equipment maker expands its presence in the country.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy